Table 4.
The Ferritin (µg/L), Hemoglobin (g/dL) Levels and Increment Rate (g/dL) from Baseline (Pre-Treatment) in ISC and LMWID Treated Groups
| ISC | LMWID |
P value |
|||
|---|---|---|---|---|---|
| n | Mean ± SD | n | Mean ± SD | ||
|
Ferritin (µg/L) Pre-Treatment |
20 | 7.500 ± 2.164 | 20 | 7.050 ± 2.114 | 0.654 |
|
Hemoglobin (g/dL) Booking |
20 | 10.355 ± 2.004 | 20 | 10.605 ± 1.723 | 0.116 |
| Treatment: | |||||
| Pre- | 20 | 8.425 ± 1.026 | 20 | 8.610 ± 0.701 | 0.091 |
| * Post - 2 weeks | 18 | 10.294 ± 0.899 | 13 | 9.923 ± 0.880 | 0.918 |
| **Post - Delivery | 19 | 10.963 ± 0.891 | 20 | 10.660 ± 1.284 | 0.084 |
| P value | < 0.0001 | < 0.0001 | |||
| Hemoglobin (g/dL) increment rate from baseline | |||||
| * Post- 2 weeks | 18 | 1.906 ± 1.101 | 13 | 1.392 ± 0.539 | 0.023 |
| **Post-Delivery | 19 | 2.542 ± 1.290 | 20 | 2.050 ± 1.073 | 0.412 |
Notes: *ISC, default (n = 1), delivered earlier than the 2 weeks follow-up date (n = 1); LMWID, default (n = 2), default due to side effects (n = 2), delivered earlier than the 2 weeks follow-up date (n = 3); **LMWID, delivered at other district hospital (n = 1).